Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2025-12-29 @ 9:23 AM
Study NCT ID:
NCT03518203
Status:
COMPLETED
Last Update Posted:
2023-09-21
First Post:
2018-03-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients
Sponsor:
Children's Hospital Medical Center, Cincinnati
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2018-7119C
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None